subscribeSubscribe
price-trendAsk Us
Acrotech Announces the Publication of Data From a Phase 1 Study of BELEODAQ®

Acrotech Announces the Publication of Data From a Phase 1 Study of BELEODAQ®
BUSINESSWIRE
26 Apr 2021
Share Share
Acrotech Announces the Publication of Data From a Phase 1 Study of BELEODAQ®

Acrotech Announces the Publication of Data From a Phase 1 Study of BELEODAQ®
BUSINESSWIRE
26 Apr 2021
Share Share
Deals and M&As this week: Alnylam Pharmaceuticals, Novartis

Deals and M&As this week: Alnylam Pharmaceuticals, Novartis
PHARMA TECH
25 Jan 2019
Share Share
Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M

Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M
Alaric Dearment MEDCITY NEWS
18 Jan 2019
Share Share
Beleodaq (belinostat) : Spectrum Pharmaceuticals vs. Fresenius Kabi

Beleodaq (belinostat) : Spectrum Pharmaceuticals vs. Fresenius Kabi
PATENT LITIGATION
19 Oct 2018
Share Share
FDA Confirms Paragraph IV Patent Challenge of Beleodaq 206256 (Belinostat) Injection

FDA Confirms Paragraph IV Patent Challenge of Beleodaq 206256 (Belinostat) Injection
FDA
01 Sep 2018
Share Share
Mundipharma licenses Spectrum`s NHL treatment, picks up Japan affiliate

Mundipharma licenses Spectrum`s NHL treatment, picks up Japan affiliate
Matthew Driskill FIERCE PHARMA ASIA
19 Nov 2015
Share Share
FDA Continues to Lead in Precision Medicine

FDA Continues to Lead in Precision Medicine
Janet Woodcock FDA VOICE
23 Mar 2015
Share Share
PMC Analysis: More Than 20 Percent of FDA\`s 2014 Novel New Drug Approvals are Personalized Medicines

PMC Analysis: More Than 20 Percent of FDA`s 2014 Novel New Drug Approvals are Personalized Medicines
PR NEWSWIRE
28 Jan 2015
Share Share